Holen Sie sich die Stockscreener-App
1.38
9.52%
0.12
Vorhandelsmarkt:
1.37
-0.010
-0.72%
Macrogenics Inc Aktie (MGNX) Neueste Nachrichten
A Closer Look at Macrogenics Inc (MGNX) Stock Gains - investchronicle.com
MacroGenics (NASDAQ:MGNX) Shares Pass Below Two Hundred Day Moving Average – Time to Sell? - Defense World
MacroGenics’ SWOT analysis: biotech firm’s stock faces pivotal year ahead By Investing.com - Investing.com India
MacroGenics’ SWOT analysis: biotech firm’s stock faces pivotal year ahead - Investing.com
MacroGenics secures $70M from Sagard in royalty deal By Investing.com - Investing.com Nigeria
MacroGenics: Working On That Road To Recovery (NASDAQ:MGNX) - Seeking Alpha
MacroGenics lands $70M 'infusion of cash' to advance clinical programs - The Business Journals
MGNX LAWSUIT ALERT: Levi & Korsinsky Notifies MacroGenics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
Traders Buy High Volume of MacroGenics Call Options (NASDAQ:MGNX) - Defense World
MacroGenics (MGNX) Secures $70M Upfront Payment in Royalty Deal - GuruFocus
MacroGenics signs financial deal with Sagard for retifanlimab - Seeking Alpha
MacroGenics, Inc. and Sagard Healthcare Partners Enter into ZYNYZ Royalty Purchase Agreement - MarketScreener
MacroGenics, Sagard Sign Zynyz Royalty Purchase Deal - MarketScreener
MacroGenics at Goldman Sachs Conference: Strategic Pipeline Expansion - Investing.com Australia
United Natural Foods, Insmed, MacroGenics - TradingView
Transcript : MacroGenics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 08 - marketscreener.com
MacroGenics at Goldman Sachs Conference: Strategic Pipeline Expansion By Investing.com - Investing.com Canada
MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Roy - GuruFocus
MacroGenics, Inc. (NASDAQ:MGNX) Shares Bought by Bank of America Corp DE - Defense World
MacroGenics secures $70M from Sagard in royalty deal - Investing.com Australia
MacroGenics, Sagard Healthcare enter into ZYNYZ royalty purchase - TipRanks
MacroGenics stock soars on royalty deal with Sagard By Investing.com - Investing.com Nigeria
MacroGenics stock soars on royalty deal with Sagard - Investing.com Australia
MacroGenics Enters Royalty Purchase Agreement with Sagard - TipRanks
MacroGenics (MGNX) Secures $70 Million Through Royalty Agreement | MGNX Stock News - GuruFocus
MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase Agreement - GlobeNewswire
Would I Choose Macrogenics Inc (NASDAQ: MGNX) Stock At Any Point In Time? - Stocksregister
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 24, 2024 in MacroGenics LawsuitMGNX - ACCESS Newswire
MacroGenics (MGNX) Accused of Misleading Investors Over Cancer Drug TrialHagens Berman - ACCESS Newswire
MacroGenics (NASDAQ:MGNX) Upgraded by Wall Street Zen to “Hold” Rating - Defense World
Ameriprise Financial Inc. Sells 26,544 Shares of MacroGenics, Inc. (NASDAQ:MGNX) - Defense World
Brokerages Set MacroGenics, Inc. (NASDAQ:MGNX) PT at $5.71 - Defense World
HAGENS BERMAN, SHAREHOLDER ADVOCATES, Encourages MacroGenics (MGNX) Investors With Significant Losses to Contact Its Attorneys, 6-Day Application Deadline is Approaching - ACCESS Newswire
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages MacroGenics (MGNX) Investors With Significant Losses to Contact Its Attorneys, 5-Day Application Deadline is Approaching in Securities Class Action - ACCESS Newswire
MacroGenics to Present at the Goldman Sachs 46th Annual Global H - GuruFocus
MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 | MGNX Stock News - GuruFocus
MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 - GlobeNewswire
MacroGenics Executives Set for Major Goldman Sachs Healthcare Conference Presentation: Watch Live - Stock Titan
Levi & Korsinsky Reminds MacroGenics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 24, 2024 – MGNX - ACCESS Newswire
MacroGenics (NASDAQ:MGNX) Upgraded to Hold at Wall Street Zen - Defense World
Levi & Korsinsky Notifies Shareholders of MacroGenics, Inc.(MGNX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
MacroGenics’ SWOT analysis: biotech firm’s stock faces pipeline challenges By Investing.com - Investing.com South Africa
MacroGenics’ SWOT analysis: biotech firm’s stock faces pipeline challenges - Investing.com
Lazard Asset Management LLC Purchases New Position in MacroGenics, Inc. (NASDAQ:MGNX) - Defense World
Northern Trust Corp Has $1.76 Million Stock Holdings in MacroGenics, Inc. (NASDAQ:MGNX) - Defense World
Millennium Management LLC Sells 671,179 Shares of MacroGenics, Inc. (NASDAQ:MGNX) - Defense World
Q2 Earnings Forecast for MacroGenics Issued By B. Riley - Defense World
MacroGenics Holds Annual Stockholders Meeting on May 21 - TipRanks
B. Riley Issues Pessimistic Forecast for MacroGenics (NASDAQ:MGNX) Stock Price - Defense World
Zacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion Technologies - Yahoo Finance
Analyst Forecasts For MacroGenics, Inc. (NASDAQ:MGNX) Are Surging Higher - simplywall.st
4 Analysts Assess Macrogenics: What You Need To Know - Benzinga
Macrogenics (MGNX) Target Price Reduced by B. Riley Securities | MGNX Stock News - GuruFocus
MacroGenics (MGNX) Sees Target Price Cut Amid Pipeline Focus | MGNX Stock News - GuruFocus
B. Riley Cuts Price Target on MacroGenics to $3 From $5, Keeps Neutral Rating - marketscreener.com
TerSera® Receives National Recognition as a 2025 USA TODAY Top Workplace - Business Wire
Stifel Nicolaus Cuts MacroGenics (NASDAQ:MGNX) Price Target to $5.00 - Defense World
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):